Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The ROSI study (Risedronate in...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The ROSI study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists.
Bibliographic Details
Main Authors:
Bradbury, L
,
Barlow, S
,
Geoghanen, F
,
Schofield, P
,
Wass, J
,
Russell, R
,
Brown, M
Format:
Conference item
Published:
2006
Holdings
Description
Similar Items
Staff View
Similar Items
The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
by: Duncan, E, et al.
Published: (2005)
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)
Fractures in Osteogenesis Imperfecta: Pathogenesis, Treatment, Rehabilitation and Prevention
by: Wouter Nijhuis, et al.
Published: (2022-02-01)
Calcitonin in osteogenesis imperfecta.
by: Smith, R, et al.
Published: (1973)
Intramedullary Nailing of Deformity and Fracture in a Patient with Osteogenesis Imperfecta
by: Hasan Göçer, et al.
Published: (2014-06-01)